{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:16:39Z","timestamp":1789787799507,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.matbio.2018.02.014","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T07:51:45Z","timestamp":1519113105000},"page":"628-636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations"],"prefix":"10.1016","volume":"68-69","author":[{"given":"Mikako","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7621","key":"10.1016\/j.matbio.2018.02.014_bb0005","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1038\/537S158a","article-title":"Gene therapy: a new chapter","volume":"537","author":"King","year":"2016","journal-title":"Nature"},{"issue":"7573","key":"10.1016\/j.matbio.2018.02.014_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.matbio.2018.02.014_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/1817-1745.111416","article-title":"Congenital myasthenic syndromes: clinical and molecular report on 7 Sicilian patients","volume":"8","author":"Pavone","year":"2013","journal-title":"J. Pediatr. Neurosci."},{"key":"10.1016\/j.matbio.2018.02.014_bb0020","series-title":"Molecular Genetics of Congenital Myasthenic Syndromes, eLS","author":"Ohno","year":"2014"},{"issue":"3","key":"10.1016\/j.matbio.2018.02.014_bb0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/cen3.12316","article-title":"Recent advances in congenital myasthenic syndromes","volume":"7","author":"Ohno","year":"2016","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"16","key":"10.1016\/j.matbio.2018.02.014_bb0030","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1073\/pnas.95.16.9654","article-title":"Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme","volume":"95","author":"Ohno","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.matbio.2018.02.014_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajhg.2009.06.015","article-title":"Identification of an agrin mutation that causes congenital myasthenia and affects synapse function","volume":"85","author":"Huze","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.matbio.2018.02.014_bb0040","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00439-011-1132-4","article-title":"LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin","volume":"131","author":"Maselli","year":"2012","journal-title":"Hum. Genet."},{"issue":"Pt 9","key":"10.1016\/j.matbio.2018.02.014_bb0045","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/brain\/awu160","article-title":"Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy","volume":"137","author":"Nicole","year":"2014","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.matbio.2018.02.014_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CND.0000000000000132","article-title":"A novel missense variant in the AGRN gene; congenital myasthenic syndrome presenting with head drop","volume":"18","author":"Karakaya","year":"2017","journal-title":"J. Clin. Neuromuscul. Dis."},{"issue":"3","key":"10.1016\/j.matbio.2018.02.014_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2008.063693","article-title":"Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome","volume":"46","author":"Maselli","year":"2009","journal-title":"J. Med. Genet."},{"issue":"8","key":"10.1016\/j.matbio.2018.02.014_bb0060","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/ajmg.a.38291","article-title":"Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission","volume":"173","author":"Maselli","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0065","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ajhg.2015.10.017","article-title":"Congenital myasthenic syndrome type 19 is caused by mutations in COL13A1, encoding the atypical non-fibrillar collagen type XIII alpha1 chain","volume":"97","author":"Logan","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"36","key":"10.1016\/j.matbio.2018.02.014_bb0070","doi-asserted-by":"crossref","first-page":"22840","DOI":"10.1074\/jbc.272.36.22840","article-title":"The mammalian gene of acetylcholinesterase-associated collagen","volume":"272","author":"Krejci","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction","volume":"165","author":"Cartaud","year":"2004","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0080","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1074\/jbc.271.4.1979","article-title":"Transient interactions between collagen-tailed acetylcholinesterase and sulfated proteoglycans prior to immobilization on the extracellular matrix","volume":"271","author":"Rossi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2018.02.014_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/1531-8249(200002)47:2<162::AID-ANA5>3.0.CO;2-Q","article-title":"The spectrum of mutations causing endplate acetylcholinesterase deficiency","volume":"47","author":"Ohno","year":"2000","journal-title":"Ann. Neurol."},{"issue":"Pt 3","key":"10.1016\/j.matbio.2018.02.014_bb0090","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.matbio.2018.02.014_bb0095","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/humu.22325","article-title":"Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction","volume":"34","author":"Nakata","year":"2013","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.matbio.2018.02.014_bb0100","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1074\/jbc.M305462200","article-title":"C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse","volume":"279","author":"Kimbell","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.matbio.2018.02.014_bb0105","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/mt.2012.34","article-title":"Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction","volume":"20","author":"Ito","year":"2012","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0110","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1083\/jcb.144.6.1349","article-title":"Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function","volume":"144","author":"Feng","year":"1999","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.matbio.2018.02.014_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","article-title":"Adeno-associated virus serotypes for gene therapeutics","volume":"24","author":"Lisowski","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.matbio.2018.02.014_bb0125","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol."},{"issue":"1","key":"10.1016\/j.matbio.2018.02.014_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.matbio.2018.02.014_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"issue":"Pt 14","key":"10.1016\/j.matbio.2018.02.014_bb0140","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1242\/jcs.115.14.2801","article-title":"The dystrophin-associated protein complex","volume":"115","author":"Ehmsen","year":"2002","journal-title":"J. Cell Sci."},{"issue":"8","key":"10.1016\/j.matbio.2018.02.014_bb0145","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1172\/JCI23755","article-title":"The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages","volume":"115","author":"Schaefer","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"36","key":"10.1016\/j.matbio.2018.02.014_bb0150","doi-asserted-by":"crossref","first-page":"24035","DOI":"10.1074\/jbc.M109.014266","article-title":"Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors","volume":"284","author":"Babelova","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2018.02.014_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2016.08.006","article-title":"The cytoprotective effect of biglycan core protein involves Toll-like receptor 4 signaling in cardiomyocytes","volume":"99","author":"Gaspar","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.matbio.2018.02.014_bb0160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ydbio.2003.12.025","article-title":"Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice","volume":"268","author":"Casar","year":"2004","journal-title":"Dev. Biol."},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0165","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.148.4.801","article-title":"The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle","volume":"148","author":"Bowe","year":"2000","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.matbio.2018.02.014_bb0170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jcp.20740","article-title":"Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development","volume":"209","author":"Rafii","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.matbio.2018.02.014_bb0175","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1359\/jbmr.2002.17.7.1180","article-title":"Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues","volume":"17","author":"Corsi","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.matbio.2018.02.014_bb0180","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1523\/JNEUROSCI.4610-11.2012","article-title":"Biglycan is an extracellular MuSK binding protein important for synapse stability","volume":"32","author":"Amenta","year":"2012","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/gim.2016.126","article-title":"Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections","volume":"19","author":"Meester","year":"2017","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0190","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ajhg.2016.04.004","article-title":"BGN mutations in X-linked spondyloepimetaphyseal dysplasia","volume":"98","author":"Cho","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"26","key":"10.1016\/j.matbio.2018.02.014_bb0195","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1093\/hmg\/11.26.3333","article-title":"Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system","volume":"11","author":"Squire","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0200","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jcph.468","article-title":"Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers","volume":"55","author":"Tinsley","year":"2015","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152840","article-title":"Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with duchenne muscular dystrophy","volume":"11","author":"Ricotti","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0210","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.matbio.2018.02.014_bb0215","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1096\/fj.05-5124fje","article-title":"Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS","volume":"20","author":"Mercado","year":"2006","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.matbio.2018.02.014_bb0220","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.1013067108","article-title":"Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice","volume":"108","author":"Amenta","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.matbio.2018.02.014_bb0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/hum.2015.088","article-title":"Protein-anchoring therapy of biglycan for mdx mouse model of Duchenne muscular dystrophy","volume":"28","author":"Ito","year":"2017","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.matbio.2018.02.014_bb0230","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1073\/pnas.1524272113","article-title":"Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease","volume":"113","author":"Khan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.matbio.2018.02.014_bb0235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","article-title":"Congenital endplate acetylcholinesterase deficiency responsive to ephedrine","volume":"65","author":"Bestue-Cardiel","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.matbio.2018.02.014_bb0240","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia","volume":"44","author":"Liewluck","year":"2011","journal-title":"Muscle Nerve"},{"issue":"21","key":"10.1016\/j.matbio.2018.02.014_bb0245","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/hmg\/ddh284","article-title":"Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities","volume":"13","author":"Zenker","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0250","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.ki.5001679","article-title":"Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders","volume":"70","author":"Hasselbacher","year":"2006","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.matbio.2018.02.014_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng1095-216","article-title":"Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy","volume":"11","author":"Helbling-Leclerc","year":"1995","journal-title":"Nat. Genet."},{"issue":"13","key":"10.1016\/j.matbio.2018.02.014_bb0260","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1073\/pnas.121027598","article-title":"Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI","volume":"98","author":"Camacho Vanegas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.matbio.2018.02.014_bb0265","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1212\/WNL.58.9.1354","article-title":"Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study","volume":"58","author":"Mercuri","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0270","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/86941","article-title":"Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene","volume":"27","author":"Arikawa-Hirasawa","year":"2001","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.matbio.2018.02.014_bb0275","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.braindev.2016.04.001","article-title":"Long-term outcomes of steroid therapy for Duchenne muscular dystrophy in Japan","volume":"38","author":"Goto","year":"2016","journal-title":"Brain Dev."},{"issue":"7616","key":"10.1016\/j.matbio.2018.02.014_bb0280","first-page":"249","volume":"536","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.matbio.2018.02.014_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1472","article-title":"Nanotherapy for Duchenne muscular dystrophy","volume":"10","author":"Nance","year":"2018","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0290","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mt.2015.5","article-title":"Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance","volume":"23","author":"Hayashita-Kinoh","year":"2015","journal-title":"Mol. Ther."},{"issue":"16","key":"10.1016\/j.matbio.2018.02.014_bb0295","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1073\/pnas.1613203114","article-title":"Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy","volume":"114","author":"Echigoya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.matbio.2018.02.014_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081302","article-title":"Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy","volume":"8","author":"Finkel","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.matbio.2018.02.014_bb0305","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1536\/ihj.15-376","article-title":"Generation of induced pluripotent stem cells from patients with Duchenne muscular dystrophy and their induction to cardiomyocytes","volume":"57","author":"Hashimoto","year":"2016","journal-title":"Int. Heart J."},{"issue":"7","key":"10.1016\/j.matbio.2018.02.014_bb0310","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1172\/JCI81380","article-title":"Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer","volume":"125","author":"Ou","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.matbio.2018.02.014_bb0315","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/hum.2015.142","article-title":"Preclinical dose-escalation study of intravitreal AAV-RS1 gene therapy in a mouse model of X-linked retinoschisis: dose-dependent expression and improved retinal structure and function","volume":"27","author":"Bush","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.matbio.2018.02.014_bb0320","doi-asserted-by":"crossref","first-page":"OCT277","DOI":"10.1167\/iovs.15-18920","article-title":"Retinal structure and gene therapy outcome in retinoschisin-deficient mice assessed by spectral-domain optical coherence tomography","volume":"57","author":"Zeng","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.matbio.2018.02.014_bb0325","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/hum.2015.044","article-title":"Challenges and prospects for alpha-1 antitrypsin deficiency gene therapy","volume":"26","author":"Wozniak","year":"2015","journal-title":"Hum. Gene Ther."},{"issue":"21","key":"10.1016\/j.matbio.2018.02.014_bb0330","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2012-10-464164","article-title":"Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia a phenotype","volume":"121","author":"Siner","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.matbio.2018.02.014_bb0335","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jth.13543","article-title":"Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A","volume":"15","author":"Nguyen","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0340","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1074\/jbc.M112.400648","article-title":"Mesencephalic astrocyte-derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors","volume":"288","author":"Henderson","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7149","key":"10.1016\/j.matbio.2018.02.014_bb0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature05957","article-title":"Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo","volume":"448","author":"Lindholm","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.matbio.2018.02.014_bb0350","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2017.01.008","article-title":"Long-term protective effects of AAV9-mesencephalic astrocyte-derived neurotrophic factor gene transfer in parkinsonian rats","volume":"291","author":"Hao","year":"2017","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.matbio.2018.02.014_bb0355","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCRESAHA.107.153023","article-title":"Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats","volume":"101","author":"Ito","year":"2007","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.matbio.2018.02.014_bb0360","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.embor.7400221","article-title":"Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment","volume":"5","author":"Nowak","year":"2004","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.matbio.2018.02.014_bb0365","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg3460","article-title":"Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches","volume":"14","author":"Fairclough","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.matbio.2018.02.014_bb0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng0996-113","article-title":"Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures","volume":"14","author":"Jobsis","year":"1996","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.matbio.2018.02.014_bb0375","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/82638","article-title":"Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)","volume":"26","author":"Nicole","year":"2000","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.matbio.2018.02.014_bb0380","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/340390","article-title":"Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia","volume":"70","author":"Arikawa-Hirasawa","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.matbio.2018.02.014_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/srep28512","article-title":"R-spondin 2 promotes acetylcholine receptor clustering at the neuromuscular junction via Lgr5","volume":"6","author":"Nakashima","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Matrix Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X17304225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X17304225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T15:23:18Z","timestamp":1660490598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0945053X17304225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":77,"alternative-id":["S0945053X17304225"],"URL":"https:\/\/doi.org\/10.1016\/j.matbio.2018.02.014","relation":{},"ISSN":["0945-053X"],"issn-type":[{"value":"0945-053X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matbio.2018.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}